| Certification: | GMP |
|---|---|
| Grade Standard: | Medicine Grade |
| Type: | API |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Lincomycin Hydrochloride Embrace the pristine purity of Lincomycin Hydrochloride, unfolding as a white crystalline powder with a distinctive slight odor and a uniquely bitter taste. This versatile compound dissolves seamlessly in water and methanol, often applied in its hydrochloride salt form for enhanced efficacy. As a powerful product of the Streptomyces genus, specifically Streptomyces lincolnensis, Lincomycin Hydrochloride stands out as a remarkable lincosamide alkaline antibiotic.
| Basic Information | |
| Product name | Lincomycin Hydrochloride |
| Grade | Pharmaceutical Grade |
| Appearance | White crystal powder |
| Assay | 99% |
| Shelf life | 3 Years |
| Packing | 25kg/drum |
| Condition | stored in a cool and dry place |
Primarily wielded for combating infections instigated by Gram-positive bacteria, Lincomycin Hydrochloride excels in treating ailments caused by penicillin-resistant strains. It is a formidable solution for poultry respiratory ailments triggered by Mycoplasma, swine enzootic pneumonia, and anaerobic infections like chicken necrotizing enterocolitis.
Furthermore, this potent antibiotic is applicable for treating treponema dysentery, toxoplasmosis, and actinomycosis in both dogs and cats, broadening its therapeutic reach across multiple species.
Lincomycin, a standout lincosamide antibiotic, is birthed from the actinomycete Streptomyces lincolnensis. Its counterpart, clindamycin, which features an altered 7-hydroxy group through chirality inversion, shares a close relation, offering a glimpse into the fascinating world of antibiotic synthesis.
Despite sharing structural similarities, antibacterial spectra, and mechanisms of action with macrolides, Lincomycin extends its efficacy to other organisms like actinomycetes, mycoplasma, and certain Plasmodium species. A single 600 mg intramuscular injection of Lincomycin achieves peak serum levels of 11.6 micrograms/ml within 60 minutes, maintaining its therapeutic promise for 17 to 20 hours against susceptible Gram-positive organisms. This efficiency is mirrored in its urinary excretion rates, which range from 1.8 to 24.8 percent, with a mean of 17.3 percent.
1. Ideal for respiratory, abdominal, female reproductive, pelvic, skin, and soft tissue infections, oral formulations of Lincomycin Hydrochloride target ailments induced by sensitive strains of Staphylococcus aureus and Streptococcus pneumoniae.
2. For more severe infections, injectable formulations rise to the occasion, adept at managing serious streptococcal, pneumococcal, and staphylococcal conditions, including surgical adjuvant therapy for septicemia, bone and joint infections, and Staphylococcus-induced acute hematogenous osteomyelitis.
3. Lincomycin Hydrochloride is particularly indispensable for individuals allergic to penicillin or unsuitable for penicillin-type medications, offering an alternative pathway for treating infectious diseases.
){kind=link}